+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Testing Market by Sample Type (Blood, Hair, Oral Fluid), Technology (Chromatography, Immunoassay, Mass Spectrometry), Test Type, End User - Global Forecast 2025-2030- Product Image
Drug Testing Market by Sample Type (Blood, Hair, Oral Fluid), Technology (Chromatography, Immunoassay, Mass Spectrometry), Test Type, End User - Global Forecast 2025-2030- Product Image
Sale

Drug Testing Market by Sample Type (Blood, Hair, Oral Fluid), Technology (Chromatography, Immunoassay, Mass Spectrometry), Test Type, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082432
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The drug testing market is experiencing rapid transformation as organizations face increasing regulatory scrutiny and the need for robust employee and public health safeguards. Today’s landscape demands advanced solutions that can address complex and evolving drug misuse challenges across a variety of industries and geographies.

Market Snapshot: The Current State of the Drug Testing Market

The Drug Testing Market grew from USD 24.94 billion in 2024 to USD 28.11 billion in 2025. It is expected to continue growing at a CAGR of 12.22%, reaching USD 49.83 billion by 2030. This growth is driven by an increased focus on public health, regulatory compliance, and the expanding complexity of substance misuse patterns. Decision-makers in corporate, healthcare, and transportation sectors are re-evaluating and upgrading drug testing frameworks to strengthen safety standards, minimize compliance risks, and sustain organizational reputation.

Scope & Segmentation: Expanding Solutions and Diverse Market Coverage

  • Sample Types: Blood (including plasma and serum), hair (body and scalp), oral fluid (stimulated and unstimulated), sweat, and urine (24-hour and spot collection) provide comprehensive matrices for detection and monitoring.
  • Technologies: Chromatography platforms (gas and liquid), immunoassays (such as ELISA and point-of-care formats), mass spectrometry (including MALDI and tandem MS), and spectroscopy (FTIR, UV) offer a broad analytical toolkit for identifying a diverse range of substances.
  • Test Types: Health screening, post-accident, pre-employment, random testing (including alcohol and drug-focused screening), and rehabilitation are widely adopted across industries to address varied risk management needs.
  • End Users: Clinics, commercial laboratories (clinical and reference), forensic (government and private), hospitals, and rehabilitation centers each have unique operational priorities and service delivery models.
  • Regional Coverage: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan) reflect distinct infrastructure maturity and market opportunities.
  • Company Coverage: Major enterprises such as Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Siemens Healthineers AG, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., and Sysmex Corporation are actively driving innovation and market consolidation.

Key Takeaways: Strategic Insights for Decision-Makers

  • Comprehensive drug testing programs are essential for risk mitigation and legal compliance in continually evolving regulatory landscapes.
  • Advancements in analytical technologies, especially in mass spectrometry and point-of-care platforms, are enabling faster, more accurate, and scalable testing protocols.
  • New behavioral trends and diversified substance use are reshaping priorities, with organizations adopting holistic strategies that balance operational efficiency and diagnostic depth.
  • Integration of digital health interfaces and laboratory information management systems is enhancing workflow automation, sample tracking, and real-time compliance monitoring.
  • Corporate strategies are shifting toward supply chain resilience, including vendor diversification, local sourcing, and strategic collaborations to manage cost volatility and procurement risks.
  • Mergers, partnerships, and R&D investments are supporting expanded detection menus, heightened assay throughput, and the development of unified service offerings.

Tariff Impact: Navigating Cost Pressures and Supply Chain Realignment

The imposition of new United States tariffs in 2025 on imported analytical equipment and reagents has increased operational costs for drug testing laboratories. This has led to a shift in procurement strategies, including greater emphasis on domestic partnerships, supply chain consolidation, and exploration of alternative suppliers. While local production efforts are growing, temporary bottlenecks and price volatility may persist. End-users are responding with shared services, new pricing frameworks, and sourcing innovations that build long-term supply chain resilience.

Methodology & Data Sources

This analysis synthesizes data from secondary sources—including scientific literature, regulatory guidelines, and industry white papers—and primary research, such as structured interviews with laboratory executives, procurement leaders, and technical specialists. Quantitative modeling and peer review processes ensure transparent, repeatable, and robust findings relevant to senior decision-makers in the drug testing sector.

Why This Report Matters

  • Supports evidence-based investment in next-generation drug testing platforms, enabling organizations to align with the latest regulatory and operational requirements.
  • Uncovers strategic segmentation, regional, and supply chain insights needed to inform procurement, risk management, and growth strategies.
  • Delivers actionable intelligence to help industry leaders anticipate trends, streamline resource allocation, and strengthen compliance frameworks.

Conclusion

The drug testing market continues to evolve through innovation, regulatory adaptation, and shifting end-user priorities. Industry participants equipped with current market intelligence can make strategic decisions that advance compliance, safety, and long-term operational performance.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of point-of-care drug screening devices with integrated digital reporting capabilities
5.2. Rising demand for hair and oral fluid testing solutions in roadside and workplace safety programs
5.3. Integration of artificial intelligence in analyzing complex drug metabolites for accurate result interpretation
5.4. Expansion of laboratory-developed tests for novel psychoactive substances to combat evolving drug abuse
5.5. Implementation of remote sample collection kits for home-based drug testing in telehealth models
5.6. Regulatory shifts driving mandatory pre-employment and post-incident drug testing protocols across industries
5.7. Development of high-throughput mass spectrometry assays to meet increasing forensic laboratory workloads
5.8. Increased collaboration between law enforcement and private labs to streamline roadside drug detection programs
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Drug Testing Market, by Sample Type
8.1. Introduction
8.2. Blood
8.2.1. Plasma
8.2.2. Serum
8.3. Hair
8.3.1. Body Hair
8.3.2. Scalp Hair
8.4. Oral Fluid
8.4.1. Stimulated
8.4.2. Unstimulated
8.5. Sweat
8.6. Urine
8.6.1. 24 Hour Urine
8.6.2. Spot Urine
9. Drug Testing Market, by Technology
9.1. Introduction
9.2. Chromatography
9.2.1. Gas Chromatography
9.2.2. Liquid Chromatography
9.3. Immunoassay
9.3.1. Elisa
9.3.2. Poc Immunoassay
9.4. Mass Spectrometry
9.4.1. Maldi
9.4.2. Tandem Ms
9.5. Spectroscopy
9.5.1. Ftir
9.5.2. Uv Spectroscopy
10. Drug Testing Market, by Test Type
10.1. Introduction
10.2. Health Screening
10.3. Post Accident
10.4. Pre Employment
10.5. Random
10.5.1. Alcohol Random
10.5.2. Drug Random
10.6. Rehabilitation
11. Drug Testing Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Commercial Laboratories
11.3.1. Clinical Laboratories
11.3.2. Reference Laboratories
11.4. Forensic Laboratories
11.4.1. Government Laboratories
11.4.2. Private Laboratories
11.5. Hospitals
11.6. Rehabilitation Centers
12. Americas Drug Testing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Drug Testing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Drug Testing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Quest Diagnostics Incorporated
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. F. Hoffmann-La Roche Ltd
15.3.4. Danaher Corporation
15.3.5. Abbott Laboratories
15.3.6. Siemens Healthineers AG
15.3.7. Bio-Rad Laboratories, Inc.
15.3.8. PerkinElmer, Inc.
15.3.9. Sysmex Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. DRUG TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DRUG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DRUG TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRUG TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRUG TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. DRUG TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. DRUG TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. DRUG TESTING MARKET: RESEARCHAI
FIGURE 24. DRUG TESTING MARKET: RESEARCHSTATISTICS
FIGURE 25. DRUG TESTING MARKET: RESEARCHCONTACTS
FIGURE 26. DRUG TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DRUG TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRUG TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DRUG TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DRUG TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DRUG TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DRUG TESTING MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG TESTING MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DRUG TESTING MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG TESTING MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DRUG TESTING MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DRUG TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG TESTING MARKET SIZE, BY HAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DRUG TESTING MARKET SIZE, BY HAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG TESTING MARKET SIZE, BY BODY HAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DRUG TESTING MARKET SIZE, BY BODY HAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG TESTING MARKET SIZE, BY SCALP HAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DRUG TESTING MARKET SIZE, BY SCALP HAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG TESTING MARKET SIZE, BY HAIR, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DRUG TESTING MARKET SIZE, BY HAIR, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG TESTING MARKET SIZE, BY STIMULATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DRUG TESTING MARKET SIZE, BY STIMULATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG TESTING MARKET SIZE, BY UNSTIMULATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DRUG TESTING MARKET SIZE, BY UNSTIMULATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG TESTING MARKET SIZE, BY SWEAT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DRUG TESTING MARKET SIZE, BY SWEAT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DRUG TESTING MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG TESTING MARKET SIZE, BY 24 HOUR URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DRUG TESTING MARKET SIZE, BY 24 HOUR URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG TESTING MARKET SIZE, BY SPOT URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DRUG TESTING MARKET SIZE, BY SPOT URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG TESTING MARKET SIZE, BY URINE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DRUG TESTING MARKET SIZE, BY URINE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG TESTING MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DRUG TESTING MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DRUG TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DRUG TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DRUG TESTING MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DRUG TESTING MARKET SIZE, BY POC IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DRUG TESTING MARKET SIZE, BY POC IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DRUG TESTING MARKET SIZE, BY MALDI, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DRUG TESTING MARKET SIZE, BY MALDI, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DRUG TESTING MARKET SIZE, BY TANDEM MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DRUG TESTING MARKET SIZE, BY TANDEM MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DRUG TESTING MARKET SIZE, BY FTIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DRUG TESTING MARKET SIZE, BY FTIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DRUG TESTING MARKET SIZE, BY UV SPECTROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DRUG TESTING MARKET SIZE, BY UV SPECTROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DRUG TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DRUG TESTING MARKET SIZE, BY HEALTH SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DRUG TESTING MARKET SIZE, BY HEALTH SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DRUG TESTING MARKET SIZE, BY POST ACCIDENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DRUG TESTING MARKET SIZE, BY POST ACCIDENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DRUG TESTING MARKET SIZE, BY PRE EMPLOYMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DRUG TESTING MARKET SIZE, BY PRE EMPLOYMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DRUG TESTING MARKET SIZE, BY RANDOM, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DRUG TESTING MARKET SIZE, BY RANDOM, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL DRUG TESTING MARKET SIZE, BY ALCOHOL RANDOM, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL DRUG TESTING MARKET SIZE, BY ALCOHOL RANDOM, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG RANDOM, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG RANDOM, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL DRUG TESTING MARKET SIZE, BY RANDOM, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL DRUG TESTING MARKET SIZE, BY REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL DRUG TESTING MARKET SIZE, BY REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL DRUG TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL DRUG TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL DRUG TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL DRUG TESTING MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL DRUG TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL DRUG TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL DRUG TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL DRUG TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL DRUG TESTING MARKET SIZE, BY GOVERNMENT LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL DRUG TESTING MARKET SIZE, BY GOVERNMENT LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL DRUG TESTING MARKET SIZE, BY PRIVATE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL DRUG TESTING MARKET SIZE, BY PRIVATE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL DRUG TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL DRUG TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL DRUG TESTING MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL DRUG TESTING MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS DRUG TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS DRUG TESTING MARKET SIZE, BY HAIR, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS DRUG TESTING MARKET SIZE, BY HAIR, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS DRUG TESTING MARKET SIZE, BY URINE, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS DRUG TESTING MARKET SIZE, BY URINE, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS DRUG TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS DRUG TESTING MARKET SIZE, BY RANDOM, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS DRUG TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS DRUG TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES DRUG TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES DRUG TESTING MARKET SIZE, BY HAIR, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES DRUG TESTING MARKET SIZE, BY HAIR, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES DRUG TESTING MARKET SIZE, BY URINE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES DRUG TESTING MARKET SIZE, BY URINE, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES DRUG TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES DRUG TESTING MARKET SIZE, BY RANDOM, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES DRUG TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES DRUG TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 185. CANADA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 186. CANADA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 187. CANADA DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 188. CANADA DRUG TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 189. CANADA DRUG TESTING MARKET SIZE, BY HAIR, 2018-2024 (USD MILLION)
TABLE 190. CANADA DRUG TESTING MARKET SIZE, BY HAIR, 2025-2030 (USD MILLION)
TABLE 191. CANADA DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2024 (USD MILLION)
TABLE 192. CANADA DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2025-2030 (USD MILLION)
TABLE 193. CANADA DRUG TESTING MARKET SIZE, BY URINE, 2018-2024 (USD MILLION)
TABLE 194. CANADA DRUG TESTING MARKET SIZE, BY URINE, 2025-2030 (USD MILLION)
TABLE 195. CANADA DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. CANADA DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. CANADA DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 198. CANADA DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 199. CANADA DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 200. CANADA DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 201. CANADA DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 202. CANADA DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 203. CANADA DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2024 (USD MILLION)
TABLE 204. CANADA DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2025-2030 (USD MILLION)
TABLE 205. CANADA DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 206. CANADA DRUG TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 207. CANADA DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2024 (USD MILLION)
TABLE 208. CANADA DRUG TESTING MARKET SIZE, BY RANDOM, 2025-2030 (USD MILLION)
TABLE 209. CANADA DRUG TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. CANADA DRUG TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. CANADA DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2024 (USD MILLION)
TABLE 212. CANADA DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2025-2030 (USD MILLION)
TABLE 213. CANADA DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 214. CANADA DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 215. MEXICO DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 216. MEXICO DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 217. MEXICO DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 218. MEXICO DRUG TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 219. MEXICO DRUG TESTING MARKET SIZE, BY HAIR, 2018-2024 (USD MILLION)
TABLE 220. MEXICO DRUG TESTING MARKET SIZE, BY HAIR, 2025-2030 (USD MILLION)
TABLE 221. MEXICO DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2024 (USD MILLION)
TABLE 222. MEXICO DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2025-2030 (USD MILLION)
TABLE 223. MEXICO DRUG TESTING MARKET SIZE, BY URINE, 2018-2024 (USD MILLION)
TABLE 224. MEXICO DRUG TESTING MARKET SIZE, BY URINE, 2025-2030 (USD MILLION)
TABLE 225. MEXICO DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. MEXICO DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. MEXICO DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 228. MEXICO DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 229. MEXICO DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 230. MEXICO DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 231. MEXICO DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 232. MEXICO DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 233. MEXICO DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2024 (USD MILLION)
TABLE 234. MEXICO DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2025-2030 (USD MILLION)
TABLE 235. MEXICO DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 236. MEXICO DRUG TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 237. MEXICO DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2024 (USD MILLION)
TABLE 238. MEXICO DRUG TESTING MARKET SIZE, BY RANDOM, 2025-2030 (USD MILLION)
TABLE 239. MEXICO DRUG TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. MEXICO DRUG TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. MEXICO DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2024 (USD MILLION)
TABLE 242. MEXICO DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2025-2030 (USD MILLION)
TABLE 243. MEXICO DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 244. MEXICO DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL DRUG TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL DRUG TESTING MARKET SIZE, BY HAIR, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL DRUG TESTING MARKET SIZE, BY HAIR, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL DRUG TESTING MARKET SIZE, BY URINE, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL DRUG TESTING MARKET SIZE, BY URINE, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL DRUG TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL DRUG TESTING MARKET SIZE, BY RANDOM, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL DRUG TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL DRUG TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA DRUG TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA DRUG TESTING MARKET SIZE, BY HAIR, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA DRUG TESTING MARKET SIZE, BY HAIR, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA DRUG TESTING MARKET SIZE, BY URINE, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA DRUG TESTING MARKET SIZE, BY URINE, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA DRUG TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA DRUG TESTING MARKET SIZE, BY RANDOM, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA DRUG TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA DRUG TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY HAIR, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY HAIR, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY URINE, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY URINE, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2024 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY RANDOM, 2025-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2024 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2025-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 335. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 336. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 337. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 338. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 339. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 340. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 341. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY HAIR, 2018-2024 (USD MILLION)
TABLE 342. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY HAIR, 2025-2030 (USD MILLION)
TABLE 343. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2024 (USD MILLION)
TABLE 344. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2025-2030 (USD MILLION)
TABLE 345. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY URINE, 2018-2024 (USD MILLION)
TABLE 346. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY URINE, 2025-2030 (USD MILLION)
TABLE 347. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 348. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 349. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 350. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 351. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 352. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 353. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 354. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 355. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2024 (USD MILLION)
TABLE 356. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2025-2030 (USD MILLION)
TABLE 357. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 358. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 359. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2024 (USD MILLION)
TABLE 360. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY RANDOM, 2025-2030 (USD MILLION)
TABLE 361. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 362. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 363. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2024 (USD MILLION)
TABLE 364. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2025-2030 (USD MILLION)
TABLE 365. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 366. UN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Drug Testing market report include:
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Sysmex Corporation

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 28.11 Billion
Forecasted Market Value ( USD ) by 2030 $ 49.83 Billion
Compound Annual Growth Rate12.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Drug of Abuse Testing Market by Sample Type (Hair, Oral Fluid, Urine), Test Technology (Chromatography, Immunoassay), End User, Drug Panel - Global Forecast 2025-2030 - Product Image

Drug of Abuse Testing Market by Sample Type (Hair, Oral Fluid, Urine), Test Technology (Chromatography, Immunoassay), End User, Drug Panel - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
At-home Drug of Abuse Testing Market by Distribution Channel (Online, Pharmacy Retail), Test Type (Multi-Drug Panel, Single Drug), Sample Type, Technology, End User - Global Forecast 2025-2030 - Product Image

At-home Drug of Abuse Testing Market by Distribution Channel (Online, Pharmacy Retail), Test Type (Multi-Drug Panel, Single Drug), Sample Type, Technology, End User - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Drug Testing Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Sample (Urine Samples), By Drug (Alcohol, Opioids), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Drug Testing Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Sample (Urine Samples), By Drug (Alcohol, Opioids), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Drug of Abuse Testing Market (By Product Type, Sample / Test Type, Drug Type, End Users / Setting Type, Country Analysis), Regulatory Status, Recent Developments, Company Profiles - Forecast to 2032 - Product Image

Drug of Abuse Testing Market (By Product Type, Sample / Test Type, Drug Type, End Users / Setting Type, Country Analysis), Regulatory Status, Recent Developments, Company Profiles - Forecast to 2032

  • Report
  • 235 Pages
  • Global
From
Employer and Workplace Drug Testing Market Size, Share and Trends Analysis Report by Type, Product, Mode, Drug, End-use, and Region 2024-2030 - Product Image

Employer and Workplace Drug Testing Market Size, Share and Trends Analysis Report by Type, Product, Mode, Drug, End-use, and Region 2024-2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.